reverses diabetes type 2

🔥+ reverses diabetes type 2 29 May 2020 There are some natural remedies or treatments patients can take to prevent or mitigate Type 2 diabetes. Natural treatments often fall under two ...

reverses diabetes type 2 The following examples apply ICD-10-CM chapter 4, "Diabetes mellitus ... note, meaning "Not coded here," appears under all the diabetes mellitus categories. ... implants, and grafts, is used to report diabetic insulin pump complications.

starchy foods to avoid for diabetes

 
Jump to: navigation, search

Diabetes mellitus main page

reverses diabetes type 2 and coronavirus (☑ statistics uk) | reverses diabetes type 2 jardiancehow to reverses diabetes type 2 for Diabetes mellitus type 2 Microchapters

Home

Patient information

Overview

Historical the 1 last update 29 May 2020 Perspective Historical Perspective

Pathophysiology

Causes

Differentiating Diabetes Mellitus Type 2 from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

reverses diabetes type 2 quizlet (👍 natural history) | reverses diabetes type 2 diet plan pdfhow to reverses diabetes type 2 for Natural History, Complications and for 1 last update 29 May 2020 Prognosis Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

reverses diabetes type 2 natural supplements (☑ young adults early death) | reverses diabetes type 2 visionhow to reverses diabetes type 2 for Chest X Ray

CT

reverses diabetes type 2 with weight loss (🔥 reversal) | reverses diabetes type 2 would be consideredhow to reverses diabetes type 2 for MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical therapy

Life Style Modification
Pharmacotherapy
Glycemic Control

Surgery

Primary Prevention

Secondary Prevention Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Seyedmahdi Pahlavani, M.D. [2]

See also Glycemic Targets in Diabetes


Overview

Glycemic control is an important measure in diabetes treatment. There are general rules for glycemic control but they should be individualized for every patients based on provider decision and patient condition.

reverses diabetes type 2 glucose levels (⭐️ range chart) | reverses diabetes type 2 symptoms in menhow to reverses diabetes type 2 for Measuring glycemic control

  • Hb A1C reflects average glycemia over approximately 3 months and has strong predictive value for diabetes complications.[1][2] Therefore, A1C should be measured as baseline control and every 3 month to see whether the treatment goals have been achieved and maintained.
  • Blood glucose, via self monitoring of blood glucose (SMBG) is accurate and easy to use by patients. It allows patients to evaluate their individual response to therapy and assess whether glycemic targets are being achieved. SMBG is mostly used for patients with type 1 diabetes mellitus but some patients with type 2 diabetes who require basal insulin will benefit from this method of monitoring. The following video shows how to apply glucometer devices for SMBG.

Libre only tells you what your blood sugar was for 1 last update 29 May 2020 in the past. Libre only tells you what your blood sugar was in the past.

The d-Nav Insulin Guidance System (Hygieia, Livonia, MI, USA) has shown benefit in a randomized controlled trial[3].

reverses diabetes type 2 use insulin (☑ yogurt) | reverses diabetes type 2 australiahow to reverses diabetes type 2 for Continuous glucose monitoring

The Miao Miao is a smartreader add for 1 last update 29 May 2020 on for the d-Nav that sends reading to a smartphone. The Miao Miao is a smartreader add on for the d-Nav that sends reading to a smartphone.

the 1 last update 29 May 2020 GoalsGoals

Evidence from trials

Forest Plot showing meta-analysis of randomized controlled trials of differing target glucose control and mortality for diabetes mellitus type 2. Note the heterogeneity due to increased death when the glycosylated hemoglobin A (Hb A1c) target was 6.0% in the ACCORD trial

A goal fasting blood glucose of below 108 mg/dl (6 mmol/L) over 10 years resulting in an Hb A1c of 7% over 10 years was found in the United Kingdom Prospective Diabetes Study (UKPDS 33) randomized controlled trial. Intensive control reduced diabetic complications in one out of every 20 patients (number needed to treat = 20).[4]

A goal fasting blood glucose of below 108 mg/dl (6 mmol/L) over 10 years resulting in an Hb A1c of 7.4% over 10.7 years in the metformin group compared to 8.0% in the conventional group in the UK Prospective Diabetes Study (UKPDS 34) randomized controlled trial. Metformin reduced cardiovascular disease in one out of every 11 patients (number needed to treat = 11).[5]

A Hb A1c of 6.9% over 6 years was found in the VA Diabetes Trial (VADT) randomized controlled trial to have no significant effect on diabetic complications.[6] Although the treatment group averaged an Hb A1c of 6.9%, the goal was 6.0%.[7]

A Hb A1c goal of 6.5% over 5 years was found in the ADVANCE randomized controlled trial not to reduce mortality using a protocol whose first step was a sulfonylurea (gliclazide). The intervention group had 0.9% less nephropathy, but more severe hypoglycemia.[8]

A Hb A1c goal of 6% over 3.5 years was found in the ACCORD randomized controlled trial found to increase serious complications.[9][10]

reverses diabetes type 2 olives (🔥 yogurt) | reverses diabetes type 2 symptomshow to reverses diabetes type 2 for The ORIGIN trial used basal insulin supplementation to reduce the Hb A1c from 6.4% to 6.2%. There was no benefit on cardiac outcomes but there was an increase in hypoglycemia and weight gain.[11]

The PROACTIVE study used pioglitazone.[12]

The older University Group Diabetes Program (UGDP) also found no benefit in a controversial randomized controlled trial.[13][14][15][16][17] The UGDP randomized approximately 1000 patients to one of five treatment groups and followed from 1962 to 1975: phenformin, tolbutamide, small fixed-dose insulin (ISTD) based on body-surface area (averaged 14 units per day), variable-dose insulin (ISTD) (averaged 45 units per day), n (IVAR), or placebo. The trial found statistically significant increase in cardiovascular deaths among the patients treated with tolbutamide and so this group was stopped in 1969. The phenformin group was also stopped early due to increased mortality. The ISTD group had no reduction in blood glucose. The IVAR group had a reduction in the IVAR group of about 2.0 mmol/L (36 mg/dL) which correlates to a 1% difference in the level of Hb A1c.[18] Problems in the trial include: 1) ""cite_ref-pmid6985989_15-1""reference""#cite_note-pmid6985989-15""cite_ref-pmid8554200_16-1""reference""#cite_note-pmid8554200-16""cite_ref-pmid8554200_16-2""reference""#cite_note-pmid8554200-16""mw-headline""Clinical_Practice_Guidelines""/index.php/American_College_of_Physicians""American College of Physicians""/index.php/American_Diabetes_Association""mw-redirect""American Diabetes Association""/index.php/HbA1c""mw-redirect""HbA1c""/index.php/American_College_of_Physicians""American College of Physicians""/index.php/Clinical_practice_guidelines""mw-redirect""Clinical practice guidelines""cite_ref-pmid29507945_19-0""reference""#cite_note-pmid29507945-19""clinicians should aim to achieve an HbA1c level between 7% and 8% in most patients with type 2 diabetes...and should consider de-intensifying pharmacologic therapy in patients with type 2 diabetes who achieve HbA1c levels less than 6.5%.""/index.php/American_Diabetes_Association""mw-redirect""American Diabetes Association""/index.php/Clinical_practice_guidelines""mw-redirect""Clinical practice guidelines""cite_ref-pmid31862749_20-0""reference""#cite_note-pmid31862749-20""cite_ref-pmid30559232_21-0""reference""#cite_note-pmid30559232-21""cite_ref-pmid31862741_22-0""reference""#cite_note-pmid31862741-22""cite_ref-pmid24983061_23-0""reference""#cite_note-pmid24983061-23""cite_ref-24""reference""#cite_note-24""/index.php/HbA1c""mw-redirect""HbA1c""Use clinical judgment to determine if a target lower than 7.0% is appropriate for an individual patient. It can be challenging to push a patient’s HbA1c levels from just above 7.0% to below 7.0%. There are potential benefits (decreased nonfatal myocardial infarction) and potential harms (hypoglycemia, weight gain, and possible increase in all-cause and cardiovascular-cause mortality) of intensive glucose therapy, especially in patients with known cardiovascular disease.""For frail elderly patients, a target HbA1c of 7.0–9.0% is reasonable""mw-headline""Frequency_goals_are_achieved""cite_ref-25""reference""#cite_note-25""cite_ref-26""reference""#cite_note-26""cite_ref-pmid24733192_27-0""reference""#cite_note-pmid24733192-27""nofollow""external text""http://www.visn16.va.gov/""cite_ref-pmid26202185_28-0""reference""#cite_note-pmid26202185-28""cite_ref-pmid22851534_29-0""reference""#cite_note-pmid22851534-29""ever achieving""mw-headline""References""reflist columns references-column-width""-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;""references""cite_note-pmid20150297-1""mw-cite-backlink""#cite_ref-pmid20150297_1-0""reference-text""citation journal""nofollow""external text""//www.ncbi.nlm.nih.gov/pmc/articles/PMC2858182""Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study""/index.php/Digital_object_identifier""Digital object identifier""nofollow""external text""//doi.org/10.2337%2Fdc09-1941""/index.php/PubMed_Central""PubMed Central""cs1-lock-free""Freely accessible""nofollow""external text""//www.ncbi.nlm.nih.gov/pmc/articles/PMC2858182""/index.php?title=PubMed_Identifier&action=edit&redlink=1""new""PubMed Identifier (page does not exist)""nofollow""external text""//www.ncbi.nlm.nih.gov/pubmed/20150297""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Diabetes+Care&rft.atitle=Effect+of+prior+intensive+insulin+treatment+during+the+Diabetes+Control+and+Complications+Trial+%28DCCT%29+on+peripheral+neuropathy+in+type+1+diabetes+during+the+Epidemiology+of+Diabetes+Interventions+and+Complications+%28EDIC%29+Study&rft.volume=33&rft.issue=5&rft.pages=1090-6&rft.date=2010&rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2858182&rft_id=info%3Apmid%2F20150297&rft_id=info%3Adoi%2F10.2337%2Fdc09-1941&rft.aulast=Albers&rft.aufirst=JW&rft.au=Herman%2C+WH&rft.au=Pop-Busui%2C+R&rft.au=Feldman%2C+EL&rft.au=Martin%2C+CL&rft.au=Cleary%2C+PA&rft.au=Waberski%2C+BH&rft.au=Lachin%2C+JM&rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2858182&rfr_id=info%3Asid%2Fwww.wikidoc.org%3ADiabetes+mellitus+type+2+Glycemic+control""Z3988""TemplateStyles:r1594688""\""""""''""https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png""https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png""https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png""cite_note-pmid10938048-2""mw-cite-backlink""#cite_ref-pmid10938048_2-0""reference-text""citation journal""nofollow""external text""//www.ncbi.nlm.nih.gov/pmc/articles/PMC27454""Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study""/index.php/PubMed_Central""PubMed Central""cs1-lock-free""Freely accessible""nofollow""external text""//www.ncbi.nlm.nih.gov/pmc/articles/PMC27454""/index.php?title=PubMed_Identifier&action=edit&redlink=1""new""PubMed Identifier (page does not exist)""nofollow""external text""//www.ncbi.nlm.nih.gov/pubmed/10938048""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=BMJ&rft.atitle=Association+of+glycaemia+with+macrovascular+and+microvascular+complications+of+type+2+diabetes+%28UKPDS+35%29%3A+prospective+observational+study&rft.volume=321&rft.issue=7258&rft.pages=405-12&rft.date=2000&rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC27454&rft_id=info%3Apmid%2F10938048&rft.aulast=Stratton&rft.aufirst=IM&rft.au=Adler%2C+AI&rft.au=Neil%2C+HA&rft.au=Matthews%2C+DR&rft.au=Manley%2C+SE&rft.au=Cull%2C+CA&rft.au=Hadden%2C+D&rft.au=Turner%2C+RC&rft.au=Holman%2C+RR&rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC27454&rfr_id=info%3Asid%2Fwww.wikidoc.org%3ADiabetes+mellitus+type+2+Glycemic+control""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r1594688""cite_note-pmid30808512-3""mw-cite-backlink""#cite_ref-pmid30808512_3-0""reference-text""citation journal""nofollow""external text""https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30808512""Automated insulin dosing guidance to optimise insulin management in patients with type 2 diabetes: a multicentre, randomised controlled trial""/index.php/Digital_object_identifier""Digital object identifier""nofollow""external text""//doi.org/10.1016%2FS0140-6736%2819%2930368-X""/index.php/PubMed_Central""PubMed Central""cs1-lock-free""Freely accessible""nofollow""external text""//www.ncbi.nlm.nih.gov/pmc/articles/PMC6715130""cs1-visible-error error citation-comment""cs1-code""/index.php?title=Help:CS1_errors&action=edit&redlink=1""new""Help:CS1 errors (page does not exist)""/index.php?title=PubMed_Identifier&action=edit&redlink=1""new""PubMed Identifier (page does not exist)""nofollow""external text""//www.ncbi.nlm.nih.gov/pubmed/30808512""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Lancet&rft.atitle=Automated+insulin+dosing+guidance+to+optimise+insulin+management+in+patients+with+type+2+diabetes%3A+a+multicentre%2C+randomised+controlled+trial.&rft.volume=393&rft.issue=10176&rft.pages=1138-1148&rft.date=2019&rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6715130&rft_id=info%3Apmid%2F30808512&rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2819%2930368-X&rft.au=Bergenstal+RM%2C+Johnson+M%2C+Passi+R%2C+Bhargava+A%2C+Young+N%2C+Kruger+DF&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Feutils%2Felink.fcgi%3Fdbfrom%3Dpubmed%26tool%3Dsumsearch.org%2Fcite%26retmode%3Dref%26cmd%3Dprlinks%26id%3D30808512&rfr_id=info%3Asid%2Fwww.wikidoc.org%3ADiabetes+mellitus+type+2+Glycemic+control""Z3988""citation-comment""display:none; color:#33aa33; margin-left:0.3em""/index.php?title=Category:CS1_maint:_Multiple_names:_authors_list&action=edit&redlink=1""new""Category:CS1 maint: Multiple names: authors list (page does not exist)""mw-deduplicated-inline-style""mw-data:TemplateStyles:r1594688""cite_note-pmid9742976-4""mw-cite-backlink""#cite_ref-pmid9742976_4-0""reference-text""citation journal""Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group""/index.php/Digital_object_identifier""Digital object identifier""nofollow""external text""//doi.org/10.1016%2FS0140-6736%2898%2907019-6""/index.php?title=PubMed_Identifier&action=edit&redlink=1""new""PubMed Identifier (page does not exist)""nofollow""external text""//www.ncbi.nlm.nih.gov/pubmed/9742976""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Lancet&rft.atitle=Intensive+blood-glucose+control+with+sulphonylureas+or+insulin+compared+with+conventional+treatment+and+risk+of+complications+in+patients+with+type+2+diabetes+%28UKPDS+33%29.+UK+Prospective+Diabetes+Study+%28UKPDS%29+Group&rft.volume=352&rft.issue=9131&rft.pages=837-53&rft.date=1998&rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2898%2907019-6&rft_id=info%3Apmid%2F9742976&rfr_id=info%3Asid%2Fwww.wikidoc.org%3ADiabetes+mellitus+type+2+Glycemic+control""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r1594688""nofollow""external text""http://www.acpjc.org/Content/130/1/ISSUE/ACPJC-1999-130-1-002.htm""cite_note-pmid9742977-5""mw-cite-backlink""#cite_ref-pmid9742977_5-0""reference-text""citation journal""nofollow""external text""http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=9742977""Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group""/index.php?title=PubMed_Identifier&action=edit&redlink=1""new""PubMed Identifier (page does not exist)""nofollow""external text""//www.ncbi.nlm.nih.gov/pubmed/9742977""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Lancet&rft.atitle=Effect+of+intensive+blood-glucose+control+with+metformin+on+complications+in+overweight+patients+with+type+2+diabetes+%28UKPDS+34%29.+UK+Prospective+Diabetes+Study+%28UKPDS%29+Group.&rft.volume=352&rft.issue=9131&rft.pages=854-65&rft.date=1998&rft_id=info%3Apmid%2F9742977&rft_id=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Feutils%2Felink.fcgi%3Fdbfrom%3Dpubmed%26retmode%3Dref%26cmd%3Dprlinks%26id%3D9742977&rfr_id=info%3Asid%2Fwww.wikidoc.org%3ADiabetes+mellitus+type+2+Glycemic+control""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r1594688""cite_note-pmid19092145-6""mw-cite-backlink""#cite_ref-pmid19092145_6-0""reference-text""citation journal""nofollow""external text""http://content.nejm.org/cgi/pmidlookup?view=short&pmid=19092145&promo=ONFLNS19""Glucose control and vascular complications in veterans with type 2 diabetes""/index.php/Digital_object_identifier""Digital object identifier""nofollow""external text""//doi.org/10.1056%2FNEJMoa0808431""/index.php?title=PubMed_Identifier&action=edit&redlink=1""new""PubMed Identifier (page does not exist)""nofollow""external text""//www.ncbi.nlm.nih.gov/pubmed/19092145""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=N.+Engl.+J.+Med.&rft.atitle=Glucose+control+and+vascular+complications+in+veterans+with+type+2+diabetes&rft.volume=360&rft.issue=2&rft.pages=129-39&rft.date=2009&rft_id=info%3Adoi%2F10.1056%2FNEJMoa0808431&rft_id=info%3Apmid%2F19092145&rft.au=Duckworth+W%2C+Abraira+C%2C+Moritz+T&rft_id=http%3A%2F%2Fcontent.nejm.org%2Fcgi%2Fpmidlookup%3Fview%3Dshort%26pmid%3D19092145%26promo%3DONFLNS19&rfr_id=info%3Asid%2Fwww.wikidoc.org%3ADiabetes+mellitus+type+2+Glycemic+control""Z3988""cs1-visible-error error citation-comment""cs1-code""/index.php?title=Help:CS1_errors&action=edit&redlink=1""new""Help:CS1 errors (page does not exist)""citation-comment""display:none; color:#33aa33; margin-left:0.3em""/index.php?title=Category:CS1_maint:_Explicit_use_of_et_al.&action=edit&redlink=1""new""Category:CS1 maint: Explicit use of et al. (page does not exist)""/index.php?title=Category:CS1_maint:_Multiple_names:_authors_list&action=edit&redlink=1""new""Category:CS1 maint: Multiple names: authors list (page does not exist)""mw-deduplicated-inline-style""mw-data:TemplateStyles:r1594688""cite_note-pmid14583175-7""mw-cite-backlink""#cite_ref-pmid14583175_7-0""reference-text""citation journal""nofollow""external text""http://linkinghub.elsevier.com/retrieve/pii/S1056872702002775""Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2: Veterans Affairs Diabetes Trial""/index.php?title=PubMed_Identifier&action=edit&redlink=1""new""PubMed Identifier (page does not exist)""nofollow""external text""//www.ncbi.nlm.nih.gov/pubmed/14583175""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Journal+of+diabetes+and+its+complications&rft.atitle=Design+of+the+cooperative+study+on+glycemic+control+and+complications+in+diabetes+mellitus+type+2%3A+Veterans+Affairs+Diabetes+Trial&rft.volume=17&rft.issue=6&rft.pages=314-22&rft.date=2003&rft_id=info%3Apmid%2F14583175&rft.au=Abraira+C%2C+Duckworth+W%2C+McCarren+M&rft_id=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1056872702002775&rfr_id=info%3Asid%2Fwww.wikidoc.org%3ADiabetes+mellitus+type+2+Glycemic+control""Z3988""citation-comment""display:none; color:#33aa33; margin-left:0.3em""/index.php?title=Category:CS1_maint:_Explicit_use_of_et_al.&action=edit&redlink=1""new""Category:CS1 maint: Explicit use of et al. (page does not exist)""/index.php?title=Category:CS1_maint:_Multiple_names:_authors_list&action=edit&redlink=1""new""Category:CS1 maint: Multiple names: authors list (page does not exist)""mw-deduplicated-inline-style""mw-data:TemplateStyles:r1594688""cite_note-pmid18539916-8""mw-cite-backlink""#cite_ref-pmid18539916_8-0""reference-text""citation journal""nofollow""external text""http://content.nejm.org/cgi/pmidlookup?view=short&pmid=18539916&promo=ONFLNS19""Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes""/index.php/Digital_object_identifier""Digital object identifier""nofollow""external text""//doi.org/10.1056%2FNEJMoa0802987""/index.php?title=PubMed_Identifier&action=edit&redlink=1""new""PubMed Identifier (page does not exist)""nofollow""external text""//www.ncbi.nlm.nih.gov/pubmed/18539916""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=N.+Engl.+J.+Med.&rft.atitle=Intensive+Blood+Glucose+Control+and+Vascular+Outcomes+in+Patients+with+Type+2+Diabetes&rft.volume=358&rft.issue=24&rft.pages=2560-2572&rft.date=2008&rft_id=info%3Adoi%2F10.1056%2FNEJMoa0802987&rft_id=info%3Apmid%2F18539916&rft_id=http%3A%2F%2Fcontent.nejm.org%2Fcgi%2Fpmidlookup%3Fview%3Dshort%26pmid%3D18539916%26promo%3DONFLNS19&rfr_id=info%3Asid%2Fwww.wikidoc.org%3ADiabetes+mellitus+type+2+Glycemic+control""Z3988""cs1-visible-error error citation-comment""cs1-code""/index.php?title=Help:CS1_errors&action=edit&redlink=1""new""Help:CS1 errors (page does not exist)""mw-deduplicated-inline-style""mw-data:TemplateStyles:r1594688""cite_note-NCBI-ACCORD-9""mw-cite-backlink""#cite_ref-NCBI-ACCORD_9-0""reference-text""citation web""nofollow""external text""http://www.nih.gov/news/health/feb2008/nhlbi-06.htm""For Safety, NHLBI Changes Intensive Blood Sugar Treatment Strategy in Clinical Trial of Diabetes and Cardiovascular Disease -""reference-accessdate""nowrap""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=unknown&rft.btitle=For+Safety%2C+NHLBI+Changes+Intensive+Blood+Sugar+Treatment+Strategy+in+Clinical+Trial+of+Diabetes+and+Cardiovascular+Disease+-&rft.pub=National+Institutes+of+Health+%28NIH%29&rft.date=2008-02-06&rft.au=Anonymous&rft_id=http%3A%2F%2Fwww.nih.gov%2Fnews%2Fhealth%2Ffeb2008%2Fnhlbi-06.htm&rfr_id=info%3Asid%2Fwww.wikidoc.org%3ADiabetes+mellitus+type+2+Glycemic+control""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r1594688""cite_note-pmid18539917-10""mw-cite-backlink""#cite_ref-pmid18539917_10-0""reference-text""citation journal""nofollow""external text""http://content.nejm.org/cgi/pmidlookup?view=short&pmid=18539917&promo=ONFLNS19""Effects of intensive glucose lowering in type 2 diabetes""/index.php/Digital_object_identifier""Digital object identifier""nofollow""external text""//doi.org/10.1056%2FNEJMoa0802743""/index.php?title=PubMed_Identifier&action=edit&redlink=1""new""PubMed Identifier (page does not exist)""nofollow""external text""//www.ncbi.nlm.nih.gov/pubmed/18539917""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=N.+Engl.+J.+Med.&rft.atitle=Effects+of+intensive+glucose+lowering+in+type+2+diabetes&rft.volume=358&rft.issue=24&rft.pages=2545-59&rft.date=2008&rft_id=info%3Adoi%2F10.1056%2FNEJMoa0802743&rft_id=info%3Apmid%2F18539917&rft.au=Gerstein+HC%2C+Miller+ME%2C+Byington+RP&rft_id=http%3A%2F%2Fcontent.nejm.org%2Fcgi%2Fpmidlookup%3Fview%3Dshort%26pmid%3D18539917%26promo%3DONFLNS19&rfr_id=info%3Asid%2Fwww.wikidoc.org%3ADiabetes+mellitus+type+2+Glycemic+control""Z3988""cs1-visible-error error citation-comment""cs1-code""/index.php?title=Help:CS1_errors&action=edit&redlink=1""new""Help:CS1 errors (page does not exist)""citation-comment""display:none; color:#33aa33; margin-left:0.3em""/index.php?title=Category:CS1_maint:_Explicit_use_of_et_al.&action=edit&redlink=1""new""Category:CS1 maint: Explicit use of et al. (page does not exist)""/index.php?title=Category:CS1_maint:_Multiple_names:_authors_list&action=edit&redlink=1""new""Category:CS1 maint: Multiple names: authors list (page does not exist)""mw-deduplicated-inline-style""mw-data:TemplateStyles:r1594688""cite_note-pmid22686416-11""mw-cite-backlink""#cite_ref-pmid22686416_11-0""reference-text""citation journal""Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia""/index.php/Digital_object_identifier""Digital object identifier""nofollow""external text""//doi.org/10.1056%2FNEJMoa1203858""/index.php?title=PubMed_Identifier&action=edit&redlink=1""new""PubMed Identifier (page does not exist)""nofollow""external text""//www.ncbi.nlm.nih.gov/pubmed/22686416""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=N+Engl+J+Med&rft.atitle=Basal+Insulin+and+Cardiovascular+and+Other+Outcomes+in+Dysglycemia.&rft.date=2012&rft_id=info%3Adoi%2F10.1056%2FNEJMoa1203858&rft_id=info%3Apmid%2F22686416&rft.au=The+ORIGIN+Trial+Investigators&rfr_id=info%3Asid%2Fwww.wikidoc.org%3ADiabetes+mellitus+type+2+Glycemic+control""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r1594688""cite_note-pmid16214598-12""mw-cite-backlink""#cite_ref-pmid16214598_12-0""reference-text""citation journal""nofollow""external text""http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16214598""Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial""/index.php/Digital_object_identifier""Digital object identifier""nofollow""external text""//doi.org/10.1016%2FS0140-6736%2805%2967528-9""/index.php?title=PubMed_Identifier&action=edit&redlink=1""new""PubMed Identifier (page does not exist)""nofollow""external text""//www.ncbi.nlm.nih.gov/pubmed/16214598""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Lancet&rft.atitle=Secondary+prevention+of+macrovascular+events+in+patients+with+type+2+diabetes+in+the+PROactive+Study+%28PROspective+pioglitAzone+Clinical+Trial+In+macroVascular+Events%29%3A+a+randomised+controlled+trial.&rft.volume=366&rft.issue=9493&rft.pages=1279-89&rft.date=2005&rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2805%2967528-9&rft_id=info%3Apmid%2F16214598&rft.au=Dormandy+JA%2C+Charbonnel+B%2C+Eckland+DJ%2C+Erdmann+E%2C+Massi-Benedetti+M%2C+Moules+IK&rft_id=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Feutils%2Felink.fcgi%3Fdbfrom%3Dpubmed%26tool%3Dsumsearch.org%2Fcite%26retmode%3Dref%26cmd%3Dprlinks%26id%3D16214598&rfr_id=info%3Asid%2Fwww.wikidoc.org%3ADiabetes+mellitus+type+2+Glycemic+control""Z3988""citation-comment""display:none; color:#33aa33; margin-left:0.3em""/index.php?title=Category:CS1_maint:_Explicit_use_of_et_al.&action=edit&redlink=1""new""Category:CS1 maint: Explicit use of et al. (page does not exist)""/index.php?title=Category:CS1_maint:_Multiple_names:_authors_list&action=edit&redlink=1""new""Category:CS1 maint: Multiple names: authors list (page does not exist)""mw-deduplicated-inline-style""mw-data:TemplateStyles:r1594688""nofollow""external text""http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16539349""nofollow""external text""http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17213077""cite_note-pmid4926376-13""mw-cite-backlink""#cite_ref-pmid4926376_13-0""reference-text""citation journal""A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results""/index.php?title=PubMed_Identifier&action=edit&redlink=1""new""PubMed Identifier (page does not exist)""nofollow""external text""//www.ncbi.nlm.nih.gov/pubmed/4926376""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Diabetes&rft.atitle=A+study+of+the+effects+of+hypoglycemic+agents+on+vascular+complications+in+patients+with+adult-onset+diabetes.+II.+Mortality+results&rft.volume=19&rft.pages=Suppl%3A789-830&rft.date=1970&rft_id=info%3Apmid%2F4926376&rft.au=Meinert+CL%2C+Knatterud+GL%2C+Prout+TE%2C+Klimt+CR&rfr_id=info%3Asid%2Fwww.wikidoc.org%3ADiabetes+mellitus+type+2+Glycemic+control""Z3988""citation-comment""display:none; color:#33aa33; margin-left:0.3em""/index.php?title=Category:CS1_maint:_Multiple_names:_authors_list&action=edit&redlink=1""new""Category:CS1 maint: Multiple names: authors list (page does not exist)""mw-deduplicated-inline-style""mw-data:TemplateStyles:r1594688""cite_note-pmid6757026-14""mw-cite-backlink""#cite_ref-pmid6757026_14-0""reference-text""citation journal""Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VIII. Evaluation of insulin therapy: final report""/index.php?title=PubMed_Identifier&action=edit&redlink=1""new""PubMed Identifier (page does not exist)""nofollow""external text""//www.ncbi.nlm.nih.gov/pubmed/6757026""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Diabetes&rft.atitle=Effects+of+hypoglycemic+agents+on+vascular+complications+in+patients+with+adult-onset+diabetes.+VIII.+Evaluation+of+insulin+therapy%3A+final+report.&rft.volume=31+Suppl+5&rft.pages=1-81&rft.date=1982&rft_id=info%3Apmid%2F6757026&rfr_id=info%3Asid%2Fwww.wikidoc.org%3ADiabetes+mellitus+type+2+Glycemic+control""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r1594688""cite_note-pmid6985989-15""mw-cite-backlink""#cite_ref-pmid6985989_15-0""#cite_ref-pmid6985989_15-1""reference-text""citation journal""nofollow""external text""http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=6985989""The Achilles heel of the University Group Diabetes Program""/index.php/Digital_object_identifier""Digital object identifier""nofollow""external text""//doi.org/10.1001%2Fjama.1980.03300310038020""/index.php?title=PubMed_Identifier&action=edit&redlink=1""new""PubMed Identifier (page does not exist)""nofollow""external text""//www.ncbi.nlm.nih.gov/pubmed/6985989""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=JAMA&rft.atitle=The+Achilles+heel+of+the+University+Group+Diabetes+Program.&rft.volume=243&rft.issue=5&rft.pages=450-7&rft.date=1980&rft_id=info%3Adoi%2F10.1001%2Fjama.1980.03300310038020&rft_id=info%3Apmid%2F6985989&rft.au=Kilo+C%2C+Miller+JP%2C+Williamson+JR&rft_id=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Feutils%2Felink.fcgi%3Fdbfrom%3Dpubmed%26retmode%3Dref%26cmd%3Dprlinks%26id%3D6985989&rfr_id=info%3Asid%2Fwww.wikidoc.org%3ADiabetes+mellitus+type+2+Glycemic+control""Z3988""citation-comment""display:none; color:#33aa33; margin-left:0.3em""/index.php?title=Category:CS1_maint:_Multiple_names:_authors_list&action=edit&redlink=1""new""Category:CS1 maint: Multiple names: authors list (page does not exist)""mw-deduplicated-inline-style""mw-data:TemplateStyles:r1594688""cite_note-pmid8554200-16""mw-cite-backlink""#cite_ref-pmid8554200_16-0""#cite_ref-pmid8554200_16-1""#cite_ref-pmid8554200_16-2""reference-text""citation journal""nofollow""external text""http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=8554200""Exogenous insulin administration and cardiovascular risk in non-insulin-dependent and insulin-dependent diabetes mellitus""/index.php?title=PubMed_Identifier&action=edit&redlink=1""new""PubMed Identifier (page does not exist)""nofollow""external text""//www.ncbi.nlm.nih.gov/pubmed/8554200""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Ann+Intern+Med&rft.atitle=Exogenous+insulin+administration+and+cardiovascular+risk+in+non-insulin-dependent+and+insulin-dependent+diabetes+mellitus.&rft.volume=124&rft.issue=1+Pt+2&rft.pages=104-9&rft.date=1996&rft_id=info%3Apmid%2F8554200&rft.au=Genuth+S&rft_id=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Feutils%2Felink.fcgi%3Fdbfrom%3Dpubmed%26retmode%3Dref%26cmd%3Dprlinks%26id%3D8554200&rfr_id=info%3Asid%2Fwww.wikidoc.org%3ADiabetes+mellitus+type+2+Glycemic+control""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r1594688""cite_note-pmid10539796-17""mw-cite-backlink""#cite_ref-pmid10539796_17-0""reference-text""citation journal""nofollow""external text""http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=10539796""Therapy of type 2 diabetes, cardiovascular death, and the UGDP""/index.php/Digital_object_identifier""Digital object identifier""nofollow""external text""//doi.org/10.1016%2FS0002-8703%2899%2970034-7""/index.php?title=PubMed_Identifier&action=edit&redlink=1""new""PubMed Identifier (page does not exist)""nofollow""external text""//www.ncbi.nlm.nih.gov/pubmed/10539796""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Am+Heart+J&rft.atitle=Therapy+of+type+2+diabetes%2C+cardiovascular+death%2C+and+the+UGDP.&rft.volume=138&rft.issue=5+Pt+1&rft.pages=S346-52&rft.date=1999&rft_id=info%3Adoi%2F10.1016%2FS0002-8703%2899%2970034-7&rft_id=info%3Apmid%2F10539796&rft.au=Feinglos+MN%2C+Bethel+MA&rft_id=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Feutils%2Felink.fcgi%3Fdbfrom%3Dpubmed%26retmode%3Dref%26cmd%3Dprlinks%26id%3D10539796&rfr_id=info%3Asid%2Fwww.wikidoc.org%3ADiabetes+mellitus+type+2+Glycemic+control""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r1594688""cite_note-pmid9448551-18""mw-cite-backlink""#cite_ref-pmid9448551_18-0""reference-text""citation journal""nofollow""external text""http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=9448551""The effects of improved glycemic control on complications in type 2 diabetes""/index.php?title=PubMed_Identifier&action=edit&redlink=1""new""PubMed Identifier (page does not exist)""nofollow""external text""//www.ncbi.nlm.nih.gov/pubmed/9448551""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Arch+Intern+Med&rft.atitle=The+effects+of+improved+glycemic+control+on+complications+in+type+2+diabetes.&rft.volume=158&rft.issue=2&rft.pages=134-40&rft.date=1998&rft_id=info%3Apmid%2F9448551&rft.au=Gaster+B%2C+Hirsch+IB&rft_id=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Feutils%2Felink.fcgi%3Fdbfrom%3Dpubmed%26retmode%3Dref%26cmd%3Dprlinks%26id%3D9448551&rfr_id=info%3Asid%2Fwww.wikidoc.org%3ADiabetes+mellitus+type+2+Glycemic+control""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r1594688""cite_note-pmid29507945-19""mw-cite-backlink""#cite_ref-pmid29507945_19-0""reference-text""citation journal""nofollow""external text""https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29507945""Hemoglobin A1c Targets for Glycemic Control With Pharmacologic Therapy for Nonpregnant Adults With Type 2 Diabetes Mellitus: A Guidance Statement Update From the American College of Physicians""/index.php/Digital_object_identifier""Digital object identifier""nofollow""external text""//doi.org/10.7326%2FM17-0939""/index.php?title=PubMed_Identifier&action=edit&redlink=1""new""PubMed Identifier (page does not exist)""nofollow""external text""//www.ncbi.nlm.nih.gov/pubmed/29507945""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Ann+Intern+Med&rft.atitle=Hemoglobin+A1c+Targets+for+Glycemic+Control+With+Pharmacologic+Therapy+for+Nonpregnant+Adults+With+Type+2+Diabetes+Mellitus%3A+A+Guidance+Statement+Update+From+the+American+College+of+Physicians.&rft.date=2018&rft_id=info%3Adoi%2F10.7326%2FM17-0939&rft_id=info%3Apmid%2F29507945&rft.au=Qaseem+A%2C+Wilt+TJ%2C+Kansagara+D%2C+Horwitch+C%2C+Barry+MJ%2C+Forciea+MA&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Feutils%2Felink.fcgi%3Fdbfrom%3Dpubmed%26tool%3Dsumsearch.org%2Fcite%26retmode%3Dref%26cmd%3Dprlinks%26id%3D29507945&rfr_id=info%3Asid%2Fwww.wikidoc.org%3ADiabetes+mellitus+type+2+Glycemic+control""Z3988""citation-comment""display:none; color:#33aa33; margin-left:0.3em""/index.php?title=Category:CS1_maint:_Explicit_use_of_et_al.&action=edit&redlink=1""new""Category:CS1 maint: Explicit use of et al. (page does not exist)""/index.php?title=Category:CS1_maint:_Multiple_names:_authors_list&action=edit&redlink=1""new""Category:CS1 maint: Multiple names: authors list (page does not exist)""mw-deduplicated-inline-style""mw-data:TemplateStyles:r1594688""cite_note-pmid31862749-20""mw-cite-backlink""#cite_ref-pmid31862749_20-0""reference-text""citation journal""nofollow""external text""https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=31862749""6. Glycemic Targets: Standards of Medical Care in Diabetes-2020""/index.php/Digital_object_identifier""Digital object identifier""nofollow""external text""//doi.org/10.2337%2Fdc20-S006""/index.php?title=PubMed_Identifier&action=edit&redlink=1""new""PubMed Identifier (page does not exist)""nofollow""external text""//www.ncbi.nlm.nih.gov/pubmed/31862749""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Diabetes+Care&rft.atitle=6.+Glycemic+Targets%3A+Standards+of+Medical+Care+in+Diabetes-2020.&rft.volume=43&rft.issue=Suppl+1&rft.pages=S66-S76&rft.date=2020&rft_id=info%3Adoi%2F10.2337%2Fdc20-S006&rft_id=info%3Apmid%2F31862749&rft.au=American+Diabetes+Association&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Feutils%2Felink.fcgi%3Fdbfrom%3Dpubmed%26tool%3Dsumsearch.org%2Fcite%26retmode%3Dref%26cmd%3Dprlinks%26id%3D31862749&rfr_id=info%3Asid%2Fwww.wikidoc.org%3ADiabetes+mellitus+type+2+Glycemic+control""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r1594688""cite_note-pmid30559232-21""mw-cite-backlink""#cite_ref-pmid30559232_21-0""reference-text""citation journal""nofollow""external text""https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30559232""6. Glycemic Targets: Standards of Medical Care in Diabetes-2019""/index.php/Digital_object_identifier""Digital object identifier""nofollow""external text""//doi.org/10.2337%2Fdc19-S006""/index.php?title=PubMed_Identifier&action=edit&redlink=1""new""PubMed Identifier (page does not exist)""nofollow""external text""//www.ncbi.nlm.nih.gov/pubmed/30559232""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Diabetes+Care&rft.atitle=6.+Glycemic+Targets%3A+Standards+of+Medical+Care+in+Diabetes-2019.&rft.volume=42&rft.issue=Suppl+1&rft.pages=S61-S70&rft.date=2019&rft_id=info%3Adoi%2F10.2337%2Fdc19-S006&rft_id=info%3Apmid%2F30559232&rft.au=American+Diabetes+Association&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Feutils%2Felink.fcgi%3Fdbfrom%3Dpubmed%26tool%3Dsumsearch.org%2Fcite%26retmode%3Dref%26cmd%3Dprlinks%26id%3D30559232&rfr_id=info%3Asid%2Fwww.wikidoc.org%3ADiabetes+mellitus+type+2+Glycemic+control""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r1594688""cite_note-pmid31862741-22""mw-cite-backlink""#cite_ref-pmid31862741_22-0""reference-text""citation journal""nofollow""external text""https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=31862741""Introduction: Standards of Medical Care in Diabetes-2020""/index.php/Digital_object_identifier""Digital object identifier""nofollow""external text""//doi.org/10.2337%2Fdc20-Sint""/index.php?title=PubMed_Identifier&action=edit&redlink=1""new""PubMed Identifier (page does not exist)""nofollow""external text""//www.ncbi.nlm.nih.gov/pubmed/31862741""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Diabetes+Care&rft.atitle=Introduction%3A+Standards+of+Medical+Care+in+Diabetes-2020.&rft.volume=43&rft.issue=Suppl+1&rft.pages=S1-S2&rft.date=2020&rft_id=info%3Adoi%2F10.2337%2Fdc20-Sint&rft_id=info%3Apmid%2F31862741&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Feutils%2Felink.fcgi%3Fdbfrom%3Dpubmed%26tool%3Dsumsearch.org%2Fcite%26retmode%3Dref%26cmd%3Dprlinks%26id%3D31862741&rfr_id=info%3Asid%2Fwww.wikidoc.org%3ADiabetes+mellitus+type+2+Glycemic+control""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r1594688""cite_note-pmid24983061-23""mw-cite-backlink""#cite_ref-pmid24983061_23-0""reference-text""citation journal""Clinical Practice Guidelines We Can Trust""/index.php?title=PubMed_Identifier&action=edit&redlink=1""new""PubMed Identifier (page does not exist)""nofollow""external text""//www.ncbi.nlm.nih.gov/pubmed/24983061""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clinical+Practice+Guidelines+We+Can+Trust&rft.date=2011&rft_id=info%3Apmid%2F24983061&rft.au=Institute+of+Medicine+%28US%29+Committee+on+Standards+for+Developing+Trustworthy+Clinical+Practice+Guidelines&rfr_id=info%3Asid%2Fwww.wikidoc.org%3ADiabetes+mellitus+type+2+Glycemic+control""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r1594688""cite_note-24""mw-cite-backlink""#cite_ref-24""reference-text""nofollow""external free""http://kpcmi.org/how-we-work/guidelines/""cite_note-25""mw-cite-backlink""#cite_ref-25""reference-text""nofollow""external text""http://www.ncqa.org/report-cards/health-plans/state-of-health-care-quality/2017-table-of-contents/diabetes-care""cite_note-26""mw-cite-backlink""#cite_ref-26""reference-text""nofollow""external text""https://www.cdc.gov/nchs/nhanes/participant.htm""cite_note-pmid24733192-27""mw-cite-backlink""#cite_ref-pmid24733192_27-0""reference-text""citation journal""nofollow""external text""https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24733192""Trends in prevalence and control of diabetes in the United States, 1988-1994 and 1999-2010""/index.php/Digital_object_identifier""Digital object identifier""nofollow""external text""//doi.org/10.7326%2FM13-2411""/index.php/PubMed_Central""PubMed Central""cs1-lock-free""Freely accessible""nofollow""external text""//www.ncbi.nlm.nih.gov/pmc/articles/PMC4442608""/index.php?title=PubMed_Identifier&action=edit&redlink=1""new""PubMed Identifier (page does not exist)""nofollow""external text""//www.ncbi.nlm.nih.gov/pubmed/24733192""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Ann+Intern+Med&rft.atitle=Trends+in+prevalence+and+control+of+diabetes+in+the+United+States%2C+1988-1994+and+1999-2010.&rft.volume=160&rft.issue=8&rft.pages=517-25&rft.date=2014&rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4442608&rft_id=info%3Apmid%2F24733192&rft_id=info%3Adoi%2F10.7326%2FM13-2411&rft.au=Selvin+E%2C+Parrinello+CM%2C+Sacks+DB%2C+Coresh+J&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Feutils%2Felink.fcgi%3Fdbfrom%3Dpubmed%26tool%3Dsumsearch.org%2Fcite%26retmode%3Dref%26cmd%3Dprlinks%26id%3D24733192&rfr_id=info%3Asid%2Fwww.wikidoc.org%3ADiabetes+mellitus+type+2+Glycemic+control""Z3988""citation-comment""display:none; color:#33aa33; margin-left:0.3em""/index.php?title=Category:CS1_maint:_Multiple_names:_authors_list&action=edit&redlink=1""new""Category:CS1 maint: Multiple names: authors list (page does not exist)""mw-deduplicated-inline-style""mw-data:TemplateStyles:r1594688""cite_note-pmid26202185-28""mw-cite-backlink""#cite_ref-pmid26202185_28-0""reference-text""citation journal""nofollow""external text""https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26202185""Glycemic and Cholesterol Control Versus Single-Goal Control in US Veterans with Newly Diagnosed Type 2 Diabetes: A Retrospective Observational Study""/index.php/Digital_object_identifier""Digital object identifier""nofollow""external text""//doi.org/10.1007%2Fs13300-015-0122-2""/index.php/PubMed_Central""PubMed Central""cs1-lock-free""Freely accessible""nofollow""external text""//www.ncbi.nlm.nih.gov/pmc/articles/PMC4575310""/index.php?title=PubMed_Identifier&action=edit&redlink=1""new""PubMed Identifier (page does not exist)""nofollow""external text""//www.ncbi.nlm.nih.gov/pubmed/26202185""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Diabetes+Ther&rft.atitle=Glycemic+and+Cholesterol+Control+Versus+Single-Goal+Control+in+US+Veterans+with+Newly+Diagnosed+Type+2+Diabetes%3A+A+Retrospective+Observational+Study.&rft.volume=6&rft.issue=3&rft.pages=339-55&rft.date=2015&rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4575310&rft_id=info%3Apmid%2F26202185&rft_id=info%3Adoi%2F10.1007%2Fs13300-015-0122-2&rft.au=Shi+L%2C+Ye+X%2C+Lu+M%2C+Wu+EQ%2C+Sharma+H%2C+Thomason+D&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Feutils%2Felink.fcgi%3Fdbfrom%3Dpubmed%26tool%3Dsumsearch.org%2Fcite%26retmode%3Dref%26cmd%3Dprlinks%26id%3D26202185&rfr_id=info%3Asid%2Fwww.wikidoc.org%3ADiabetes+mellitus+type+2+Glycemic+control""Z3988""citation-comment""display:none; color:#33aa33; margin-left:0.3em""/index.php?title=Category:CS1_maint:_Explicit_use_of_et_al.&action=edit&redlink=1""new""Category:CS1 maint: Explicit use of et al. (page does not exist)""/index.php?title=Category:CS1_maint:_Multiple_names:_authors_list&action=edit&redlink=1""new""Category:CS1 maint: Multiple names: authors list (page does not exist)""mw-deduplicated-inline-style""mw-data:TemplateStyles:r1594688""cite_note-pmid22851534-29""mw-cite-backlink""#cite_ref-pmid22851534_29-0""reference-text""citation journal""nofollow""external text""https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22851534""Simultaneous control of diabetes mellitus, hypertension, and hyperlipidemia in 2 health systems""/index.php/Digital_object_identifier""Digital object identifier""nofollow""external text""//doi.org/10.1161%2FCIRCOUTCOMES.111.963553""/index.php/PubMed_Central""PubMed Central""cs1-lock-free""Freely accessible""nofollow""external text""//www.ncbi.nlm.nih.gov/pmc/articles/PMC3590111""/index.php?title=PubMed_Identifier&action=edit&redlink=1""new""PubMed Identifier (page does not exist)""nofollow""external text""//www.ncbi.nlm.nih.gov/pubmed/22851534""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Circ+Cardiovasc+Qual+Outcomes&rft.atitle=Simultaneous+control+of+diabetes+mellitus%2C+hypertension%2C+and+hyperlipidemia+in+2+health+systems.&rft.volume=5&rft.issue=5&rft.pages=645-53&rft.date=2012&rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3590111&rft_id=info%3Apmid%2F22851534&rft_id=info%3Adoi%2F10.1161%2FCIRCOUTCOMES.111.963553&rft.au=Schroeder+EB%2C+Hanratty+R%2C+Beaty+BL%2C+Bayliss+EA%2C+Havranek+EP%2C+Steiner+JF&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Feutils%2Felink.fcgi%3Fdbfrom%3Dpubmed%26tool%3Dsumsearch.org%2Fcite%26retmode%3Dref%26cmd%3Dprlinks%26id%3D22851534&rfr_id=info%3Asid%2Fwww.wikidoc.org%3ADiabetes+mellitus+type+2+Glycemic+control""Z3988""citation-comment""display:none; color:#33aa33; margin-left:0.3em""/index.php?title=Category:CS1_maint:_Multiple_names:_authors_list&action=edit&redlink=1""new""Category:CS1 maint: Multiple names: authors list (page does not exist)""mw-deduplicated-inline-style""mw-data:TemplateStyles:r1594688""printfooter""https://www.wikidoc.org/index.php?title=Diabetes_mellitus_type_2_Glycemic_control&oldid=1607035""catlinks""catlinks""interface""mw-normal-catlinks""mw-normal-catlinks""/index.php/Special:Categories""Special:Categories""/index.php?title=Category:CS1_errors:_PMC&action=edit&redlink=1""new""Category:CS1 errors: PMC (page does not exist)""/index.php?title=Category:CS1_maint:_Multiple_names:_authors_list&action=edit&redlink=1""new""Category:CS1 maint: Multiple names: authors list (page does not exist)""/index.php?title=Category:Pages_with_citations_using_unsupported_parameters&action=edit&redlink=1""new""Category:Pages with citations using unsupported parameters (page does not exist)""/index.php?title=Category:CS1_maint:_Explicit_use_of_et_al.&action=edit&redlink=1""new""Category:CS1 maint: Explicit use of et al. (page does not exist)""text-align:center;""nomobile""wikidocNav""/index.php/Main_Page""Main Page""/index.php/WikiPatient""WikiPatient""/index.php/Category:Up-To-Date""Category:Up-To-Date""/index.php/Special:RecentChanges""Special:RecentChanges""/index.php/Special:NewFiles""Special:NewFiles""/index.php/Special:AllPages""Special:AllPages""/index.php/Category:List_of_Diseases""Category:List of Diseases""/index.php/The_WikiDoc_Living_Textbook_of_Signs_and_Symptoms""The WikiDoc Living Textbook of Signs and Symptoms""/index.php/The_WikiDoc_Living_Textbook_of_Physical_Examination""The WikiDoc Living Textbook of Physical Examination""/index.php/The_WikiDoc_Living_Textbook_of_Laboratory_Findings""The WikiDoc Living Textbook of Laboratory Findings""/index.php/The_WikiDoc_Living_Textbook_of_Pharmacology""The WikiDoc Living Textbook of Pharmacology""/index.php/NewPage""mw-redirect""New Page""/index.php/Editor_Application""Editor Application""mw-redirect""/index.php/Help_Menu""Help Menu""/index.php/Firstpage""Firstpage""mw-redirect""/index.php/Help:Editing""Help:Editing""mw-redirect""/index.php/Special:Upload""Special:Upload""/index.php?title=Diabetes_mellitus_type_2_Glycemic_control&printable=yes""/index.php/Special:SpecialPages""Special:SpecialPages""/index.php/Special:WhatLinksHere""Special:WhatLinksHere""index.php/WikiDoc_Quality_Improvement_Project""visualClear""/index.php/There_is_No_Industry_Support_for_This_Site""There is No Industry Support for This Site""/index.php/WikiDoc_foundation_donations""WikiDoc foundation donations""/index.php/Editorial_Board""Editorial Board""/index.php/WikiDoc_Foundation_governance""WikiDoc Foundation governance""/index.php/WikiDoc_Licensing""WikiDoc Licensing""/index.php/wikidoc:General_disclaimer""wikidoc:General disclaimer""/index.php/How_to_avoid_plagiarism""How to avoid plagiarism""/index.php/Policies""Policies""mw-redirect""position:relative; margin-left:auto; margin-right:auto; width:400px; ""http://www.linkedin.com/search?search=&currentCompany=C&company=WikiDoc+Foundation&sortCriteria=R&keepFacets=true""Linked-in.jpg""vertical-align:top;""/images/6/67/Linked-in.jpg""26""26""https://twitter.com/share""twitter-share-button""Check out this WikiDoc article!""large""none""https://twitter.com/wikidoc""twitter-follow-button""false""large""visualClear""mw-navigation""mw-head""p-personal""navigation""""p-personal-label""p-personal-label""pt-anontalk""/index.php/Special:MyTalk""Discussion about edits from this IP address [n]""n""pt-anoncontribs""/index.php/Special:MyContributions""A list of edits made from this IP address [y]""y""pt-login""/index.php?title=Special:UserLogin&returnto=Diabetes+mellitus+type+2+Glycemic+control""You are encouraged to log in; however, it is not mandatory [o]""o""pt-createaccount""/index.php/Special:RequestAccount""You are encouraged to create an account and log in; however, it is not mandatory""left-navigation""p-namespaces""navigation""vectorTabs""p-namespaces-label""p-namespaces-label""ca-Home2""http://www.wikidoc.org/index.php/Main_Page""ca-nstab-main""selected""/index.php/Diabetes_mellitus_type_2_Glycemic_control""View the content page [c]""c""ca-talk""new""/index.php?title=Talk:Diabetes_mellitus_type_2_Glycemic_control&action=edit&redlink=1""Discussion about the content page [t]""t""discussion""p-variants""navigation""vectorMenu emptyPortlet""p-variants-label""p-variants-label""#""menu""right-navigation""p-views""navigation""vectorTabs""p-views-label""p-views-label""ca-view""selected""/index.php/Diabetes_mellitus_type_2_Glycemic_control""ca-viewsource""/index.php?title=Diabetes_mellitus_type_2_Glycemic_control&action=edit""This page is protected. You can view its source [e]""e""ca-history""collapsible""/index.php?title=Diabetes_mellitus_type_2_Glycemic_control&action=history""Past revisions of this page [h]""h""ca-Help""collapsible""http://www.wikidoc.org/index.php/Category:Help""p-cactions""navigation""vectorMenu emptyPortlet""p-cactions-label""p-cactions-label""#""menu""p-search""search""searchInput""/index.php""searchform""simpleSearch""search""search""Search wikidoc""Search wikidoc [f]""f""searchInput""hidden""Special:Search""title""submit""fulltext""Search""Search the pages for this text""mw-searchButton""searchButton mw-fallbackSearchButton""submit""go""Go""Go to a page with this exact name if it exists""searchButton""searchButton""mw-panel""p-logo""banner""mw-wiki-logo""/index.php/Main_Page""Visit the main page""portal""navigation""body""t-whatlinkshere""/index.php/Special:WhatLinksHere/Diabetes_mellitus_type_2_Glycemic_control""A list of all wiki pages that link here [j]""j""t-recentchangeslinked""/index.php/Special:RecentChangesLinked/Diabetes_mellitus_type_2_Glycemic_control""nofollow""Recent changes in pages linked from this page [k]""k""t-specialpages""/index.php/Special:SpecialPages""A list of all special pages [q]""q""t-print""/index.php?title=Diabetes_mellitus_type_2_Glycemic_control&printable=yes""alternate""Printable version of this page [p]""p""t-permalink""/index.php?title=Diabetes_mellitus_type_2_Glycemic_control&oldid=1607035""Permanent link to this revision of the page""t-info""/index.php?title=Diabetes_mellitus_type_2_Glycemic_control&action=info""More information about this page""t-smwbrowselink""/index.php/Special:Browse/:Diabetes-5Fmellitus-5Ftype-5F2-5FGlycemic-5Fcontrol""search""footer""contentinfo""footer-info""footer-info-credits""/index.php/User:Badgettrg""User:Badgettrg""/index.php/User:Fatimo_Biobaku""User:Fatimo Biobaku""/index.php/User:Mehdi_Pahlavani""User:Mehdi Pahlavani""footer-info-copyright""external""nofollow""http://creativecommons.org/licenses/by-sa/3.0/""footer-places""footer-places-privacy""/index.php/wikidoc:Privacy_policy""wikidoc:Privacy policy""footer-places-about""/index.php/wikidoc:About""wikidoc:About""footer-places-disclaimer""/index.php/wikidoc:General_disclaimer""wikidoc:General disclaimer""footer-places-mobileview""https://www.wikidoc.org/index.php?title=Diabetes_mellitus_type_2_Glycemic_control&mobileaction=toggle_view_mobile""noprint stopMobileRedirectToggle""footer-icons""noprint""footer-copyrightico""http://creativecommons.org/licenses/by-sa/3.0/""http://i.creativecommons.org/l/by-sa/3.0/80x15.png""Creative Commons Attribution/Share-Alike License""88""31""footer-poweredbyico""//www.mediawiki.org/""/resources/assets/poweredby_mediawiki_88x31.png""Powered by MediaWiki""/resources/assets/poweredby_mediawiki_132x47.png 1.5x, /resources/assets/poweredby_mediawiki_176x62.png 2x""88""31""https://www.semantic-mediawiki.org/wiki/Semantic_MediaWiki""/extensions/SemanticMediaWiki/includes/../res/images/smw_button.png""Powered by Semantic MediaWiki""88""31""clear:both">